A nurse is caring for a client who is receiving cisplatin for treatment of ovarian cancer. The client's most recent complete blood count (CBC) is shown in the table below. It is important for the nurse to consider which of the following for the client? WBC 1,400/mm3 RBC 4.3 x 1012/L Hgb 12.1 g/dL Hct 36.5% Platelets 170,000/mm3 Albumin 4.5 g/dL

A. Increased risk for bleeding is generally associated with thrombocytopenia (platelets <150,000/mm&sup3;). This client’s platelet count is 170,000/mm&sup3;, which is within the normal range, so bleeding risk is not significantly increased. B. Increased protein diet may be beneficial for general health or wound healing, but the client’s albumin level is normal (4.5 g/dL), indicating adequate nutritional status. Protein supplementation is not immediately indicated. C. Erythropoiesis-stimulating agents are used to treat anemia. This client’s hemoglobin (12.1 g/dL) and hematocrit (36.5%) are within normal limits, so ESA therapy is not indicated at this time. D. The client’s WBC count is 1,400/mm&sup3;, indicating leukopenia (normal range 4,500–11,000/mm&sup3;) and a significant reduction in neutrophils. Cisplatin can cause bone marrow suppression, increasing susceptibility to infection. Nursing interventions should include infection precautions, monitoring for fever, and client education on signs of infection.